aTyr Pharma is launching a new clinical trial for a drug called Efzofitimod, which has thus far shown significant promise as a drug that reduces dependence on prednisone for pulmonary sarcoidosis patients. In addition, the drug has also produced positive results in helping patients improve their overall condition and quality of life. In this episode of the Sarc Fighter Podcast, aTyr CEO Dr. Sanjay Shukla joins me to talk about testing to date, and to announce what could be the final stretch of testing and analysis before Efofitimod reaches FDA approval, and would then be available to treat sarcoidosis patients.
Will this be the first significant breakthrough in 20 years? Listen in as Dr. Shulka walks us through the successes so far and what must still happen for Efzofitimod to become available for patients.
Payment is being processed by .
Please wait while the order is being comfirmed.
Payment Processing
Your order is processing, and it may take up to a few days for the service provider to handle your payment. Please kindly stay tuned and check your order status in ‘User Center’.
About Order Status
Completed: Your order has been successfully paid.
Cancelled: Your expired order will turn to "Cancelled".
Failed: Your order was not successfully processed due to payment error.
Processing: Your order is processing, and it may take a few days for the service provider to handle your payment. Once it notifies us the payment result, we will change the status of the order.